Theravance Biopharma TBPH Operating margin

Operating margin at other companies

Gyre Therapeutics, Inc.GYRE

-14%-18.7pp

Rigel PharmaceuticalsRIGL

41.6%+19.9pp

LQD

Liquidia CorporationLQDA

-155%-68.1pp

Royalty PharmaRPRX

59.6%-20.2pp

United TherapeuticsUTHR

44.4%-2.6pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

FAQ

What is Theravance Biopharma's operating margin?

Theravance Biopharma (TBPH) reported operating margin of 1.2% in Q1 2026.

How has Theravance Biopharma's operating margin changed year-over-year?

Theravance Biopharma's operating margin increased by 101.6% year-over-year, from -76.9% to 1.2%.

What is the long-term trend for Theravance Biopharma's operating margin?

Over 5 years (2020 to 2025), Theravance Biopharma's operating margin has grown at a -61.8% compound annual growth rate (CAGR), from -414.4% to -3.4%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.